Your browser doesn't support javascript.
loading
Effects of riluzole on psychiatric disorders with anxiety or fear as primary symptoms: A systematic review.
Kawashima, Yoshitaka; Yamada, Misa; Furuie, Hiroki; Kuniishi, Hiroshi; Akagi, Kie; Kawashima, Tomoko; Noda, Takamasa; Yamada, Mitsuhiko.
Affiliation
  • Kawashima Y; Department of Neuropsychopharmacology, National Institute of Mental Health, National Center of Neurology and Psychiatry, Tokyo, Japan.
  • Yamada M; Clinical Psychology Course, Department of Psycho-Social Studies, School of Arts and Letters, Meiji University, Tokyo, Japan.
  • Furuie H; Department of Neuropsychopharmacology, National Institute of Mental Health, National Center of Neurology and Psychiatry, Tokyo, Japan.
  • Kuniishi H; Department of Neuropsychopharmacology, National Institute of Mental Health, National Center of Neurology and Psychiatry, Tokyo, Japan.
  • Akagi K; Department of Neuropsychopharmacology, National Institute of Mental Health, National Center of Neurology and Psychiatry, Tokyo, Japan.
  • Kawashima T; Department of Neuropsychopharmacology, National Institute of Mental Health, National Center of Neurology and Psychiatry, Tokyo, Japan.
  • Noda T; Department of Neuropsychopharmacology, National Institute of Mental Health, National Center of Neurology and Psychiatry, Tokyo, Japan.
  • Yamada M; Department of Psychiatry, National Center Hospital, National Center of Neurology and Psychiatry, Tokyo, Japan.
Neuropsychopharmacol Rep ; 43(3): 320-327, 2023 09.
Article in En | MEDLINE | ID: mdl-37463744

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Riluzole / Obsessive-Compulsive Disorder Type of study: Clinical_trials / Diagnostic_studies / Guideline / Prognostic_studies / Systematic_reviews Limits: Humans Language: En Journal: Neuropsychopharmacol Rep Year: 2023 Document type: Article Affiliation country: Japan Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Riluzole / Obsessive-Compulsive Disorder Type of study: Clinical_trials / Diagnostic_studies / Guideline / Prognostic_studies / Systematic_reviews Limits: Humans Language: En Journal: Neuropsychopharmacol Rep Year: 2023 Document type: Article Affiliation country: Japan Country of publication: United States